Inventor

TORRI GIANGIACOMO

IT32 patents

⚠️ This page may combine multiple inventors who share the name “TORRI GIANGIACOMO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TORRI GIANGIACOMO

NOVAHEALTH BIOSYSTEMS LLC

Carboxylated derivatives of glycosaminoglycans and use as drugs

Carboxylated derivatives of glycosaminoglycans and use as drugs

Derivatives of N-desulfated glycosaminoglycans and use as drugs

Derivatives of N-desulfated glycosaminoglycans and use as drugs

Carboxylated derivatives of glycosaminoglycans and use as drugs

CRINOS INDUSTRIA FARMACO

Sulfoamino derivatives of chondroitin sulfates of dermatan sulfate and of hyaluronic acid and their pharmacological properties

Polyalkylene resins crosslinked with diisocyanate used for selective separation of heparin from other glucosaminoglycanes

Process for the isolation and purification of monosialoganglioside from a starting lipidic mixture by complexation with alpha-cyclodextrin and related intermediate compound

Process for the isolation and purification of monosialoganglioside from a starting lipidic mixture by complexation with alfa-cyclodextrin and related intermediate compound

MASSACHUSETTS INST TECHNOLOGY

Method for sequence determination using NMR

Method for sequence determination using NMR

Method for sequence determination using NMR

SANOFI SA

Process for the depolymerization and sulfation of polysaccharides

Process for preparing EDTA-free heparins, heparin fractions and fragments

CASU BENITO

Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect

Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect

BAXTER INT

Peritoneal dialysis solution containing modified icodextrins

Peritoneal dialysis solution containing modified icodextrins

PROCTER & GAMBLE

Cationic polymer

SCLAVO

Depolymerized and supersulfated heparin, process for its preparation and pharmaceutical compositions

INALCO SPA

Glycosaminoglycans having high antithrombotic activity

SIGMA TAU RES SWITZERLAND SA

Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect

SIGMA TAU IND FARMACEUTI

Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect

GRACE ITALIANA SPA

Process for controlled degradation of liquid glucose syrups and cement additive products therefrom

NICOX SA

Nitroderivatives of polysaccharides

CRINOS IND FARMABIOLOG

Polyaminic resin for the selective separation of heparin from other glucosaminoglycanes and method for the preparation thereof

ISTITUTO SCIENT DI CHIMICA E B

Semi-synthetic sulphaminoheparosansulphates having high anti-metastatic activity and reduced haemorrhagic risk

MASSACHUSSETTS INST OF TECHNOLOGY

Method for sequence determination using NMR

EDMOND PHARMA SRL

Inclusion complexes of dipyridamole with cyclodextrins

TORRI GIANGIACOMO

Mimetics of sulfated oligosaccharides

DERIVATI ORGANICI LAB

Multistep process for the physical depolymerization of heparin and products obtained therefrom

NEXT TECHNOLOGY TECNOTESSILE S

Free-radical functionalized polysaccharides